Inder Bhamra

Inder Bhamra currently serves as Chief Scientific Officer at Refoxy Pharma since March 2025. Prior to this role, Inder Bhamra spent over a decade at Redx Pharma, holding various titles including Vice President Head of Chemistry and DMPK, Vice President Drug Discovery, Research Fellow, Principal Scientist, and Medicinal Chemistry Team Leader from April 2013 to March 2025. Inder Bhamra's earlier experience includes positions at Redx Oncology as a Medicinal Chemist, University of Liverpool as a Postdoctoral Research Associate, and Bradford Pharma as a Research Chemist. Additionally, Inder Bhamra worked at University of Liverpool as a Teaching Fellow and Senior Research Associate, and at GlaxoSmithKline as a Synthetic Chemist. Inder Bhamra's academic background includes a PhD in Organolithium Chemistry and an MChem in Chemistry, both from the University of Liverpool.